ENTPD1 and hepatocellular carcinoma: Elevated levels of CD39 have also been found in tumors resected for hepatocellular carcinoma, gastric carcinoma, and head and neck squamous cell carcinoma, where higher expression is associated with the likelihood of recurrence after surgery and/or poor overall survival.